AR027035A1 - Pirroles sustituidos - Google Patents
Pirroles sustituidosInfo
- Publication number
- AR027035A1 AR027035A1 ARP000106792A ARP000106792A AR027035A1 AR 027035 A1 AR027035 A1 AR 027035A1 AR P000106792 A ARP000106792 A AR P000106792A AR P000106792 A ARP000106792 A AR P000106792A AR 027035 A1 AR027035 A1 AR 027035A1
- Authority
- AR
- Argentina
- Prior art keywords
- heteroaryl
- substituted
- heterocycle
- pharmaceutically acceptable
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Se describen pirroles sustituidos que tienen la formula (1). Estos compuestos y sus sales farmacéuticamente aceptables son utiles en el tratamiento y/ocontrol de trastornos de proliferacion celular, en particular cáncer. Asimismo se describen composi ciones farmacéuticas que contienen los compuestosprecedentes. En donde los sustituyentes de la formula (1) son N R1 y R1 son independientemente hidrogeno, alquilo inferior, alquenilo inferior o alquiniloinferior; R2 es hidrogeno, nitro, ciano, haloge no, alquilo inferior, alquenilo inferior, alquinilo inferior, o alcoxilo inferior; y R2 es un heteroarilo,heterociclo, etilo sustituido por un heteroarilo, o etoxilo sustituido por un heteroarilo o heterociclo; o una sal respectiva farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17155799P | 1999-12-22 | 1999-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR027035A1 true AR027035A1 (es) | 2003-03-12 |
Family
ID=22624198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106792A AR027035A1 (es) | 1999-12-22 | 2000-12-20 | Pirroles sustituidos |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6281356B1 (es) |
| EP (1) | EP1242409A2 (es) |
| JP (1) | JP2003518112A (es) |
| KR (1) | KR100508741B1 (es) |
| CN (1) | CN1193027C (es) |
| AR (1) | AR027035A1 (es) |
| AU (1) | AU782920B2 (es) |
| BR (1) | BR0016516A (es) |
| CA (1) | CA2394852A1 (es) |
| CO (1) | CO5090902A1 (es) |
| CZ (1) | CZ20022492A3 (es) |
| HK (1) | HK1054382A1 (es) |
| HR (1) | HRP20020536A2 (es) |
| HU (1) | HUP0204572A3 (es) |
| IL (1) | IL150200A0 (es) |
| JO (1) | JO2199B1 (es) |
| MA (1) | MA26860A1 (es) |
| MX (1) | MXPA02006162A (es) |
| MY (1) | MY133682A (es) |
| NO (1) | NO20022927L (es) |
| NZ (1) | NZ519359A (es) |
| PE (1) | PE20011098A1 (es) |
| PL (1) | PL357603A1 (es) |
| RU (1) | RU2261862C2 (es) |
| UY (1) | UY26498A1 (es) |
| WO (1) | WO2001046178A2 (es) |
| YU (1) | YU46302A (es) |
| ZA (1) | ZA200204313B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030139373A1 (en) * | 2001-11-20 | 2003-07-24 | Breimer Lars Holger | Method for cancer therapy |
| PE20040079A1 (es) | 2002-04-03 | 2004-04-19 | Novartis Ag | Derivados de indolilmaleimida |
| GB0303319D0 (en) | 2003-02-13 | 2003-03-19 | Novartis Ag | Organic compounds |
| JP6325078B2 (ja) | 2013-03-15 | 2018-05-16 | プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． | ヘテロ環式化合物およびその使用 |
| US20140303121A1 (en) | 2013-03-15 | 2014-10-09 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
| DK3272745T3 (da) * | 2016-07-21 | 2019-09-02 | Inst Farmakologii Polskiej Akademii Nauk | Imidazolylsubstituerede indolderivater, der binder 5-ht7-serotoninreceptor, og farmaceutiske sammensætninger deraf |
| EP3694855A1 (en) | 2017-10-13 | 2020-08-19 | Plexxikon Inc. | Solid forms of a compound for modulating kinases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89167A (en) | 1988-02-10 | 1994-02-27 | Hoffmann La Roche | Substituted pyrroles, their manufacture and pharmaceutical compositions containing them |
| US5380746A (en) | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| IL94274A0 (en) * | 1989-05-05 | 1991-03-10 | Goedecke Ag | Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same |
| CA2130836A1 (en) * | 1992-03-20 | 1993-09-30 | Martin J. Slater | Further indole derivatives with antiviral activity |
| EP0630241A1 (en) | 1992-03-20 | 1994-12-28 | The Wellcome Foundation Limited | Indole derivatives with antiviral activity |
| DE4217964A1 (de) * | 1992-05-30 | 1993-12-02 | Goedecke Ag | Indolocarbazol-Imide und deren Verwendung |
| PE91598A1 (es) | 1996-07-29 | 1998-12-24 | Hoffmann La Roche | Pirroles sustituidos |
| PE91498A1 (es) | 1996-07-29 | 1998-12-22 | Hoffmann La Roche | Pirroles sustituidos |
| PE91698A1 (es) | 1996-07-29 | 1998-12-24 | Hoffmann La Roche | Pirroles sustituidos |
| BR9908882A (pt) * | 1998-03-17 | 2000-11-21 | Hoffmann La Roche | Bisindolimaleimidas substituìdas para a inibição de proliferação de célula |
-
2000
- 2000-12-15 US US09/737,685 patent/US6281356B1/en not_active Expired - Fee Related
- 2000-12-19 JO JO2000203A patent/JO2199B1/en active
- 2000-12-20 MY MYPI20006018A patent/MY133682A/en unknown
- 2000-12-20 CO CO00096628A patent/CO5090902A1/es unknown
- 2000-12-20 AR ARP000106792A patent/AR027035A1/es not_active Application Discontinuation
- 2000-12-21 RU RU2002119557/04A patent/RU2261862C2/ru not_active IP Right Cessation
- 2000-12-21 CN CNB008173885A patent/CN1193027C/zh not_active Expired - Fee Related
- 2000-12-21 NZ NZ519359A patent/NZ519359A/en unknown
- 2000-12-21 AU AU37267/01A patent/AU782920B2/en not_active Ceased
- 2000-12-21 YU YU46302A patent/YU46302A/sh unknown
- 2000-12-21 HU HU0204572A patent/HUP0204572A3/hu unknown
- 2000-12-21 MX MXPA02006162A patent/MXPA02006162A/es not_active Application Discontinuation
- 2000-12-21 UY UY26498A patent/UY26498A1/es not_active Application Discontinuation
- 2000-12-21 BR BR0016516-6A patent/BR0016516A/pt not_active IP Right Cessation
- 2000-12-21 IL IL15020000A patent/IL150200A0/xx unknown
- 2000-12-21 EP EP00991984A patent/EP1242409A2/en not_active Withdrawn
- 2000-12-21 JP JP2001547088A patent/JP2003518112A/ja active Pending
- 2000-12-21 CZ CZ20022492A patent/CZ20022492A3/cs unknown
- 2000-12-21 WO PCT/EP2000/013026 patent/WO2001046178A2/en not_active Application Discontinuation
- 2000-12-21 PE PE2000001386A patent/PE20011098A1/es not_active Application Discontinuation
- 2000-12-21 PL PL00357603A patent/PL357603A1/xx not_active Application Discontinuation
- 2000-12-21 CA CA002394852A patent/CA2394852A1/en not_active Abandoned
- 2000-12-21 KR KR10-2002-7008019A patent/KR100508741B1/ko not_active IP Right Cessation
-
2002
- 2002-05-29 ZA ZA200204313A patent/ZA200204313B/en unknown
- 2002-06-18 NO NO20022927A patent/NO20022927L/no not_active Application Discontinuation
- 2002-06-20 HR HR20020536A patent/HRP20020536A2/hr not_active Application Discontinuation
- 2002-06-21 MA MA26707A patent/MA26860A1/fr unknown
-
2003
- 2003-09-15 HK HK03106619A patent/HK1054382A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0204572A2 (en) | 2003-05-28 |
| MXPA02006162A (es) | 2002-12-05 |
| KR100508741B1 (ko) | 2005-08-17 |
| NO20022927D0 (no) | 2002-06-18 |
| CO5090902A1 (es) | 2001-10-30 |
| UY26498A1 (es) | 2001-06-29 |
| MA26860A1 (fr) | 2004-12-20 |
| AU782920B2 (en) | 2005-09-08 |
| AU3726701A (en) | 2001-07-03 |
| CA2394852A1 (en) | 2001-06-28 |
| NZ519359A (en) | 2004-04-30 |
| ZA200204313B (en) | 2003-08-29 |
| WO2001046178A3 (en) | 2001-12-06 |
| YU46302A (sh) | 2005-06-10 |
| PE20011098A1 (es) | 2001-10-26 |
| KR20020062365A (ko) | 2002-07-25 |
| HRP20020536A2 (en) | 2004-08-31 |
| MY133682A (en) | 2007-11-30 |
| JO2199B1 (en) | 2003-12-23 |
| RU2002119557A (ru) | 2004-01-10 |
| RU2261862C2 (ru) | 2005-10-10 |
| WO2001046178A2 (en) | 2001-06-28 |
| JP2003518112A (ja) | 2003-06-03 |
| CN1193027C (zh) | 2005-03-16 |
| IL150200A0 (en) | 2002-12-01 |
| EP1242409A2 (en) | 2002-09-25 |
| US6281356B1 (en) | 2001-08-28 |
| CN1411457A (zh) | 2003-04-16 |
| CZ20022492A3 (cs) | 2003-02-12 |
| HUP0204572A3 (en) | 2004-07-28 |
| PL357603A1 (en) | 2004-07-26 |
| HK1054382A1 (en) | 2003-11-28 |
| BR0016516A (pt) | 2002-09-17 |
| NO20022927L (no) | 2002-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0105414A2 (hu) | Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| NO20060219L (no) | Forbindelser | |
| DE69413542D1 (de) | Perhydroisoindolderivate als substanz p antagonisten | |
| AR006906A1 (es) | Derivados de indazol sustituidos, composiciones farmaceuticas que los contienen, uso de los mismos e intermediarios de sintesis | |
| AR036042A1 (es) | Derivados aralquilsufonil-3-(pirrol-2-ilmetiliden)-2-indolinona, sus composiciones farmaceuticas y metodo para la modulacion de la actividad catalitica de una proteina quinasa | |
| AR048642A1 (es) | Compuestos de metil-aril o heteroaril-amida sustituida utiles como antagonistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento | |
| SE0202463D0 (sv) | Novel compounds | |
| NZ330973A (en) | Azolobenzazepine derivatives as neurologically active agents | |
| ES2121441T3 (es) | Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco | |
| ES2188194T3 (es) | 1,8-naftiridin-4(1h)-onas sustituidas como inhibidores de la fosfodiesterasa 4. | |
| FI970317A (fi) | Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä | |
| ATE260275T1 (de) | Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one | |
| CO4990932A1 (es) | Derivados de 2,1,3-benzotiadiazol y proceso para su preparacion | |
| NO20000722L (no) | 2-(4-aryl eller heteroaryl-piperazin-1-ylmetyl)-1H- indolderivater | |
| ATE249440T1 (de) | Flüssige benzisochinoline derivate | |
| AR045791A1 (es) | Derivados de triazol sustituidos como antagonistas de oxitocina | |
| IL136359A (en) | Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same | |
| ATE273281T1 (de) | Heterozyklische cytotoxische wirkstoffe | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
| MX9306310A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| PE20021018A1 (es) | DERIVADOS DE ß - CARBOLINA | |
| AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
| AP2001002188A0 (en) | 5HT1 antagonists for antidepressant therapy. | |
| AR027035A1 (es) | Pirroles sustituidos | |
| DK0461958T3 (da) | 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |